Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.
A coordinated action from government agencies, health professionals and citizens is needed to tackle dengue, as it is no ...
Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results